TABLE 1.

Baseline characteristics of patients treated with miltefosine and included in the pharmacokinetic analysis (n = 31)

Parameter	Median value (interquartile range)
Age (yr)	24 (23-29)
No. of males/no. of females	30/1
Weight (kg)	85 (78-89)
Height (cm)	184 (180-188)
Dose (mg/kg/day)	1.76 (1.69-1.92)
No. of blood samples per patient	13 (9-20a)
During treatment	8 (6-13a)
After end of treatment	5 (1-12a)
No. of patients with prior treatment with intralesional SbVb/no. of patients naïve to treatment	30/1

^aRange.

^b100 mg SbV/ml, given as 0.1 to 0.3 ml three times every other day for 1 to 3 weeks.